RxDoctor Payments Data

Sara Nashi, MD

Interventional Pain Medicine · Cincinnati, OHNPI 1699087080

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $88,861 of the $115,804 with a category attached, or 76.7%. Boston Scientific accounts for 87.6% of it on its own, with 22 other manufacturers making up the rest. Among interventional pain medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,804in general payments, 2019–2025

Across 442 payments — averaging $262.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$101K
  • Abbott$7K
  • Relievant Medsystems, Inc.$3K
  • Medtronic$1K
  • SPR Therapeutics, Inc$771
  • Nevro Corp.$673
  • plus $2K from 17 others
$24,635in research payments, 2019–2025

Across 6 payments — averaging $4105.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$25K

What the payments were for

  • Consulting fees$3,2383%
  • Speaking & faculty fees$88,86177%
  • Travel & lodging$11,32710%
  • Food & beverage$12,37711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,804 in reported general payments places this provider in the 95th percentile of 67 interventional pain medicine providers in Ohio.

See all interventional pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$143,031
Medicare patients
341
Services billed
3,949

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl12$13,308
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$962
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen29$867
Gabapentin62$604
Oxycodone Hcl25$432
Methocarbamol26$425
Duloxetine Hcl16$331
Tramadol Hcl33$258
Cyclobenzaprine Hcl20$202
Pregabalin12$141
Tizanidine Hcl15$122
Cephalexin30$82
Prednisone13$53
Meloxicam12$35

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →